Malignant gliomas extensively in®ltrate the surrounding normal brain, and their diuse invasion is one of the most important barriers to successful therapy. Recent studies indicate that the progression of gliomas from lowgrade to high-grade may depend on the acquisition of a new phenotype and the subsequent addition of genetic defects. One of the most frequent abnormalities in the progression of gliomas is the inactivation of tumorsuppressor gene p16, suggesting that loss of p16 is associated with acquisition of malignant characteristics. Consistent with this hypothesis, our previous studies showed that restoring wild-type p16 activity into p16-null malignant glioma cells modi®ed their phenotype. In order to understand whether the biological consequences of p16 inactivation in high-grade gliomas included facilitating invasiveness, we used a recombinant replication-de®cient adenovirus carrying the cDNA of the p16/CDKN2 gene to infect and express high levels of p16 protein in p16-null SNB19 glioma cells. Invasion of SNB19 glioma cells was tested into two models: invasion of glioma cells through Matrigel-coated transwell inserts and invasion of tumor-cell spheroids into fetal rat-brain aggregates in a co-culture system. Matrigel invasion assays showed that the SNB19 cells expressing exogenous p16 exhibited signi®cantly reduced invasion. Similarly, invasion of p16-treated SNB19 cells into fetal rat-brain aggregates was reduced during a 72 h time period compared to invasion of the adenovirus-control and mock-infected cells. Expression of matrix metalloproteinase-2 (MMP-2), an enzyme involved in tumor-cell invasion, in SNB19 cells expressing p16 was signi®cantly reduced compared to that of parental SNB19 and vector-infected cells. Our results show that restoring wild-type p16 activity into p16-null SNB19 glioma cells signi®cantly inhibits tumorcell invasion, thus suggesting a novel function of the p16 gene.
Introduction
The tumor-suppressor gene p16/CDKN2 (Kamb et al., 1994; Serrano et al., 1993; localized to the 9p21 chromosomal region encodes a Mr 16 000 protein (p16). p16, when bound to CDK4, prevents the association of CDK4 with cyclin D1 and the subsequent phosphorylation of critical substrates necessary for transit through the G 1 phase of the cell cycle (Serrano et al., 1993) . Expression of p16 is transcriptionally regulated by the retinoblastoma gene product pRb (Li et al., 1994) . The p16/CDKN2 has been found inactivated in many cancers and in more than 50% of the high-grade and malignant gliomas examined (Giani and Finocchiaro, 1994; Jen et al., 1994; Schmidt et al., 1994) . Consistent with this, transgenic mice with impaired expression of endogenous p16 protein suer from spontaneous development of tumors (Serrano et al., 1996) , substantiating the role of p16/CDKN2 as a tumor suppressor gene. Restoring p16 activity in glioma cells inhibited cell growth (Arap et al., 1995) by blocking the progression of the cells through the G 1 phase and modi®ed the transformed phenotype (Fueyo et al., 1996b) . Moreover, a recent study demonstrated that loss of p16 expression correlated with the invasive stage and with tumor progression in melanomas (Reed et al., 1995) .
One of the most important obstacles to the successful therapy of high-grade gliomas is their ability to in®ltrate and invade the surrounding normal tissue. Glioma invasion involves cell adhesion and proteolytic modi®cation of the extracellular matrix (Liotta and Stetler-Stevenson, 1990; Giese and Westphal, 1996) . Among the extracellular matrix-degrading proteinases, 72 kDa gelatinase-B (MMP-2) in particular has been consistently correlated with the invasive activity of human glioma cells (Nakagawa et al., 1996; Sawaya et al., 1996; Uhm et al., 1996) . Although control of the expression of MMP-2 activity is still under intense examination, it has been reported that MMP-2 activity is regulated both positively and negatively by growth factors and oncogenes (Mignatti and Rifkin, 1993) . In gliomas, activation of MMP-2 is observed in the high grades but not in the low grades of malignancy, suggesting that its activity contributes to the invasive capability of malignant gliomas. Although substantial progress has been made in understanding the invasive behaviour of malignant gliomas in vitro and in vivo (Bjerkvig et al., 1986; Mohanam et al., 1993; Rao et al., 1994; Go et al., 1996; Giese and Westphal, 1996) , the factors responsible for invasiveness are both poorly understood and poorly documented. Since the ability to invade seems to be correlated with the degree of malignancy, and since p16 activity is characteristically lost during the progression of gliomas from low grade to high grade, we sought to determine whether inactivation of the p16 protein plays a role in glioma invasion. Using an adenoviral vector Ad5RSV-p16, we restored wild-type p16 activity to SNB19 human glioma cells and then assayed the invasion of p16-expressing glioma cells in two dierent systems in vitro. Invasion of SNB19 cells expressing p16 was signi®cantly reduced in both assay systems. Finally, we determined the expression of MMP-2, an enzyme responsible for glioma invasion, before and after exogenous p16 expression, and we found that SNB19 cells expressing p16 had signi®cantly lower levels of MMP-2. These ®ndings indicate that loss of p16/CDKN2 expression deregulates both cell invasion and MMP-2 expression in gliomas. The results obtained by transferring p16/ CDKN2 were compared with those obtained by transferring p21, another negative regulator of the cell cycle progression, which induced growth arrest of SNB19 cells but did not modify their ability to invade. These data indicate an enhanced role of p16/ CDKN2 as a major tumor-suppressor gene in gliomas and broadened the features of its anticancer activity.
Results

Gene transfer eciency
SNB19 cells growing in monolayer were stained with X-Gal to determine LacZ expression. X-Gal staining showed that about 80% of the cells in monolayer were stained positive after infection with Ad5CMV-LacZ at a MOI of 100 PFU/cell (Figure 1a) . Spheroids of SNB19 were also stained positive after transfection with Ad5CMV-LacZ. Scoring the blue cells in this assay could not be performed as minutely as in monolayer cultures. Nevertheless, the spheroids were almost completely blue after infection with the vector expressing the reporter gene, re¯ecting that the majority of the cells were infected (Figure 1b) . These results were consistent with those of previous studies using dierent human glioma cells (Gomez-Manzano et al., 1996) . In addition to the b-gal assay, we examined the transduction eciency of the Ad5RSV-p16 by immunohistochemistry (Figure 1c) . Using a single dose of 100 MOI, more than 80% of the SNB19 cells showed p16 positive immunostaining 72 h after the infection with the Ad5RSV-p16. The exogenous p16 protein was localized predominantly in the nucleus of the glioma cells.
p16, p21 and Rb expressions in SNB19 human glioma cells Western-blot analysis showed that endogenous p16 was absent and the level of expression of endogenous p21 was hardly detectable in parental SNB19 glioma cells, but was clearly observable 72 h after the infection of glioma cells with Ad5RSV-p16 and Ad5CMV-p21, respectively (Figure 2a and b) . Since the p16 and p21 proteins only exert their negative cell growth regulation if Rb protein is present, we determined whether SNB19 cells expressed endogenous Rb protein. Western blot analysis con®rmed the presence of Rb protein ( Figure  2c ).
Growth arrest mediated by exogenous p16 and p21 proteins
To con®rm that the newly expressed p16 and p21 proteins induce growth arrest of SNB19 glioma cells in the G 1 phase of the cell cycle, we performed¯ow-cytometric studies to examine the eect of exogenous wild-type p16 and p21 expression on the cell cycle of exponentially growing SNB19 cells. On the third day after infection, 85.5% of the p16-treated and 77% of the p21-treated SNB19 cells (versus 53% and 50% of p16 but not p21 expression, inhibits invasion of SNB19 cells through Matrigel
Invasion, one of the important hallmarks of malignant gliomas, was assayed in transwell inserts precoated with reconstituted basement membrane, Matrigel. When cells were placed at a density of 1610 6 cells/ml in the upper chamber, staining of p16-treated SNB19 cells invaded through the Matrigel was signi®cantly decreased compared to parental SNB19 cells and vector-infected cells (Figure 4a ). Quantitative analysis of the number of cells by MTT assay (Mohanam et al., 1993) showed that 43% of parental SNB19 cells and about 37% of vector-treated SNB19 cells invaded to the lower side of the membrane after 48 h (Figure 4c ). In contrast, invasion of SNB19 cells expressing exogenous p16 was signi®cantly reduced: only 13% could be found on the lower side of the membrane. In order to rule out that the reduction in invasion is due to growth arrest induced by p16, we infected SNB19 cells with Ad5CMV-p21 and assayed the invasion through matrigel. Invasion assays (Figure 4b ) showed that p21 transfer had no eect on the invasion of SNB19 cells. p21-treated cells invaded equally well compared to mock and virus control-treated SNB19 cells (40%) (Figure 4d ), suggesting that p21 overexpression did not inhibit invasion.
Inhibition of SNB19 spheroid invasion into rat-brain aggregates
To examine the invasion of SNB19 cells in a more appropriate three-dimensional system, we co-cultured tumor spheroids and fetal rat-brain aggregates that had been stained with¯uorescent dyes, DiI or DiO prior to the co-culture. Staining the cells with these dyes allows better visualization and characterization of the invasive pattern using confocal laser scanning microscopy than is possible with the Matrigel assays. In the co-culture assays, spheroids and rat-brain aggregates initially attached to each other, and by 72 h, tumor spheroids from parental SNB19 cells (Figure 5a , green fluorescence) progressively invaded into rat-brain aggregates (Figure 5a , red¯uorescence) and only a fraction of the original rat-brain aggregate could be seen (Figure 5a ). Similarly, spheroids from adenovirus control-infected SNB19 cells (Ad5CMV-pA, Figure 5a ) showed a diusive invasion into fetal-rat brain aggregates. In contrast, invasion of SNB19 cells expressing exogenous p16 protein was completely inhibited (Ad5RSV-p16, Figure 5a ). Again to consolidate the speci®city of p16 in invasion, similar co-culture experiments were performed with Ad5CMV-p21-infected SNB19 spheroids. Light microscopic examination showed that compared to parental SNB19 cells, p21-treated spheroids invaded equally well ( Figure 5b ) and p21 overexpression had no eect on the invasion into fetal rat-brain aggregates.
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Inhibition of invasion correlates with reduction in MMP-2
Since the cells expressing p16 protein were less invasive in both Matrigel and co-culture assays, we determined the expression of MMP-2, an enzyme responsible for extracellular matrix degradation and which plays a vital role in glioblastoma invasion. The gelatinolytic pro®le in Figure 6a showed that parental SNB19 cells expressed 72 kDa type IV collagenase in cell conditioned medium. In contrast, SNB19 cells infected with the Ad5RSV-p16 gene were found to express reduced levels of this enzyme. SNB19 cells infected with virus control, however, had enzymatic activity similar to that of parental SNB19 cells. Similarly, MMP-2 enzyme activity was assayed by gelatin zymography in the conditioned medium from Ad5CMV-p21-infected cells. Compared to parental SNB19 cells, vector and p21-treated cells had similar enzyme activity (Figure 6b ) showing that p21 overexpression had no eect on MMP-2 activity.
Discussion
Our data demonstrate a link between expression of the p16 gene and signi®cant reduction of the invasive ability of glioma cells. Therapeutic strategies designed to restore wild-type p16 activity in gliomas are particularly appealing, since p16 is the most frequent tumor-suppressor gene altered in human malignant gliomas and its inactivation constitutes one of the most common genetic abnormalities in high-grade gliomas (Collins and James, 1993; Giani and Finocchiaro, 1994; Gelatin zymographic analysis of MMP-2 in conditioned medium of parental and p16-expressing (a) and p21-overexpressing (b) SNB19 cells. Samples of equal amount (50 mg protein) were electrophoresed on SDS ± PAGE gels containing gelatin as substrate to detect enzyme activity. For details see Materials and methods p16 suppresses glioma invasion SK Chintala et al Jen et al., 1994; Schmidt et al., 1994; Fueyo et al., 1996a; Ueki et al., 1996) . The adenoviral vector used in our investigation to eciently express exogenous wildtype p16 (Ad5RSV-p16) (Fueyo et al., 1996b) is an excellent tool owing to its ability to infect glioma cells and the very low toxicity of adenoviral vectors in vitro and in vivo brain cell systems (Akli et al., 1993; Le Gal La Salle et al., 1993) . The results of this work and two previous studies (Arap et al., 1995; Fueyo et al., 1996b) indicate that overexpression of an exogenous wild-type p16 in glioma cells that do not express endogenous p16 modi®es the transformed phenotype of the cancer cells. Thus,¯ow-cytometric analysis demonstrated synchronization of the cancer cells in G 0 /G 1 (2n DNA) phase of the cell cycle. These results are consistent with current knowledge about p16 as a negative regulator of cell-cycle progression. The complexity of the cancercontrol pathways of tumor-suppressor genes, however, involves other aspects of the biology of the tumors (Rastinejad et al., 1989; Merzak et al., 1994; Van Meir et al., 1994; Hsu et al., 1996) , in addition to blocking cell-cycle progression. In this regard, it has been reported that inactivation of p16 correlates with high invasive stage in melanomas, indicating that loss of p16 possibly provides a selective advantage for the development of invasive cells (Reed et al., 1995) . In gliomas, as in melanomas, p16 is expressed in lowgrade and inactivated in high-grade malignant tumors. Therefore, loss of p16 expression in anaplastic gliomas might also result from for low-grade gliomas acquiring new biological characteristics, such as increase in invasion capability (Nowell, 1976) . Our results show that infection with Ad5RSV-p16 resulted in growth arrest of SNB19 cells at the G 0 /G 1 cell cycle. To ascertain whether the block in the cell cycle progression plays any role in the decrease of the ability of p16-expressing glioma cells to invade, SNB19 cells were blocked in G 1 by transferring an exogenous p21. p21-treatment induced G 1 arrest, as expected, but did not interfere with the capability of glioma cells to invade. Interestingly, micro-cell mediated transfer of chromosome 6, where the p21 gene is located, to human melanoma cells did not modify their invasiveness in vitro or in vivo (Welch et al., 1993; Miele et al., 1996) . These data are consistent with a previous study showing that transfer of the Rb cDNA to cancer cells decrease their invasiveness in a cell-cycle independent way (Li et al., 1996) . In addition, the invasive capacity of aphidicolin-or hydroxiurea-synchronized hepatoma cells enriched in G 1 /early S phase was higher than that of asynchronous cells (Iwasaki et al., 1995) . Moreover, studies of the relationship between cell cycle and in vitro migration have shown that an increase in lymphocyte migration occurs in G 1 phase but not in S or G 2 /M phases (Wilkinson 1986; Ratner et al., 1988; Masuyama et al., 1992) . Taken together these observations suggest that the anti-invasion properties of the p16/CDKN2 gene would not be related to the cell-growth regulatory ability. Therefore, the anticancer eect of p16/CDKN2 may be modulated by at least two independent factors: p16-mediated growth arrest and suppression of invasiveness.
SNB19 cells expressing wild-type p16 had reduced invasive ability through Matrigel. To further con®rm the eect of p16 transfer on invasion, we utilized a three-dimensional co-culture model that closely mimics in vivo invasion into a complex and intact extracellular matrix synthesized by fetal rat-brain aggregates under confocal laser scanning microscopy (Nygaard et al., 1995) , which gives the added advantage of observing tumor-cell invasion at dierent depths by optical sectioning. As in the Matrigel assays, SNB19 spheroids treated with p16 failed to invade the fetal rat-brain aggregates. The results obtained with both systems present functional evidence of reduced invasiveness of high-grade glioma cells by the p16 transfer.
Because cellular invasion depends on proteolytic modi®cation of the extracellular matrix as well as on cell adhesion, we were led to determine whether transfer of p16 modi®es the expression of matrix metalloproteinases. Several studies have implicated the expression of the MMP-2 with invasive process in vitro and in vivo (Albelda, 1993; Mignatti and Rifkin, 1993, Chintala et al., 1996; Sawaya et al., 1996) . The expression of such molecules is induced by several oncogenes and can be suppressed by dierent pharmacological agents and growth factors (Mignatti and Rifkin, 1993) . Interestingly, transforming growth factor beta, which upregulates p15, a cyclin-kinasecyclin complex inhibitor that shares very strong structural and functional homology with the p16 gene (Hannon and Beach, 1994) , blocks the induction of MMP (Kerr et al., 1990) . The expression of MMP-2 varies with the degree of malignancy and it has been shown that high-grade gliomas express greater levels of MMP-2 than do low-grade gliomas . Since the inactivation of p16 and increased expression of MMP-2 are coincident in high-grade gliomas, we next examined whether the restoration of the p16 gene would in¯uence MMP-2 activity. Interestingly, the activity of this proteinase by gelatin substrate zymography was reduced after the transfer of p16. Therefore, the exogenous wild-type p16 cDNA modi®ed invasion and the proteolytic activity of p16-defective SNB19 glioma cells, impairing dramatically their ability to invade in vitro. The fact that loss of p16 is coincident with expression of MMP-2 in high-grade gliomas suggests that their abnormalities may function in an additive manner to promote the invasive phenotype of human malignant gliomas. Further experiments are in progress to ascertain the precise intracellular signaling mechanisms of control of MMP-2 expression by the tumor-suppressor gene p16.
Materials and methods
Generation of recombinant adenoviral vector Ad5RSV-p16
The recombinant adenovirus Ad5RSV-p16 was constructed by following a previously published procedure (Zhang et al., 1993) and has been reported in detail elsewhere (Fueyo et al., 1996b) . Brie¯y, a gene expression minicassette containing a 800 bp fragment of wild-type p16 cDNA that includes the entire protein-coding sequence (Serrano et al., 1993) , driven by the Rous sarcoma virus promoter, and a bovine growth hormone polyadenylation signal were placed in the deleted E1 region of an adenovirus serotype 5. The control virus Ad5CMV-pA was generated in the same manner and had a similar structure to that of Ad5RSV-p16 without the p16 cDNA. The deletion of the E1 region rendered the Ad5RSV-p16 replication de®cient. High-titer infectious Ad5RSV-p16 viral stocks were prepared after the replication of recombinant adenoviral p16 suppresses glioma invasion SK Chintala et al vector in the human kidney cell line 293, which contains a functional E1 gene that provides the necessary transacting E1a protein. The Ad5CMV-p21 was a generous gift of Dr Wei-Wei Zhang (Eastham et al., 1995) , UTMD Anderson Cancer Center, Houston.
Cell lines and infection conditions
An established human glioma cell line SNB19 (kindly provided by Dr Richard Morrison, MD Anderson Cancer Center, Houston, TX) (Go et al., 1996; Mohanam et al., 1997) was used in the current study. The cells were maintained in Dulbecco's modi®ed Eagle's medium/F12 medium (1:1, v/v) supplemented with 10% fetal calf serum in a humidi®ed atmosphere containing 5% CO 2 at 378C. The media and serum were purchased from Sigma Chemical Co. (St. Louis, MO). Infection of the cell lines was carried out according to a previously reported technique (Fueyo et al., 1996b; Gomez-Manzano et al., 1996) . The viral stock was diluted to multiplicity of infection of 100 plaque forming units per cell, added to either cell monolayers or tumor-cell spheroids (0.5 ml per 60 mm dish or 3 ml per 100 mm dish), and incubated at 378C for 30 min with a brief agitation for every 5 min. The necessary amount of culture medium was then added, and the cells were returned to the incubator.
b-Galactosidase transduction assay
To assess the ability of the adenoviral vectors to infect the SNB19 cells, both monolayer and tumor spheroids of SNB19 human glioma cells were infected with an adenovirus carrying the E-coli b-galactosidase gene under the control of the human cytomegalovirus promoter (Ad5CMV-LacZ), and 24 h later they were stained with X-Gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside). Increasing doses of the adenovirus, from 0 to 200 MOI, were used to ascertain the MOI necessary to infect 80% or more of a bulk population of SNB19 cells. The percentages of b-gal-positive cells were obtained from scoring 500 cells each on triplicate dishes.
Immunocytochemistry assay
After 72 h the infected cell monolayers were ®xed with acetone. Immunostaining was performed using the Vectastain Elite kit (Vector Laboratories Inc., Burlingame, CA). The primary antibody used was rabbit anti-human p16 polyclonal antibody (PharMingen, San Diego, CA) and the secondary antibody was a biotin-labeled anti-rabbit IgG antibody (Vector Laboratories Inc.). ABC was used at 1:75 dilution for 30 min at room temperature. The chromogen was diaminobenzidine.
Immunoblotting analysis
Total cell lysates were prepared by incubating the cells in RIPA buer (150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS, 20 mM EDTA and 50 mM Tris, pH 7.4) for 1 h at 48C. Twenty micrograms of protein from each sample was subjected to either 12% (p16 and p21) or 7% (Rb) SDS-Tris-glycine gel electrophoresis and transferred to a nitrocellulose membrane (Schleicher & Schuell Inc., Keene, NH). The membrane was blocked with BlottoTween (3% nonfact milk, 0.05% Tween 20, 0.9% NaCl and 50 mM Tris, pH 7.5) and incubated with either rabbit anti-human p16 polyclonal antibody C-20 (Santa Cruz Biotechnology, Inc. CA) or rabbit anti-human p21 polyclonal antibody C-19 (Santa Cruz Biotechnology, Inc., CA), or rabbit anti-Rb polyclonal antibody C-15 (Santa Cruz Biotechnology, Inc.). Mouse anti-human bactin monoclonal antibody (Amersham Corp., Arlington Heights, IL) was used as a loading control. The secondary antibodies were horseradish peroxidase-conjugated donkey anti-rabbit and goat anti-mouse IgG (Amersham Corp., Arlington Heights, IL). The membranes were developed by ECL reagent according to manufacturer's protocol (Amersham, Arlington Heights, IL).
Flow cytometric assay
To measure DNA content, 10 6 cells infected with either Ad5RSV-p16 or Ad5CMV-p21 or Ad5CMV-pA or treated only with medium (mock infected) were trypsinized 3 days after infection, ®xed in 70% cold ethanol, and incubated with propidium iodide (50 mg/ml) and ribonuclease (20 mg/ml) for 20 min at 378C. All measurements were made with an EPICS pro®le (Coulter Coporation, Hialeah, FL) equipped with an air-cooled argon ion laser emitting 488 nm at 15 mW. A minimum of 10 000 events per sample were analysed and¯uorescein isothiocyanate¯uorescence was collected with a 525BP ®lter. Coulter's Cytologic program was used for data analysis. The mean peak uorescence was determined for each histogram.
Matrigel invasion assay
Invasion of the glioma cells in vitro was measured by the invasion of cells through Matrigel-coated (Collaborative Research, Inc., Boston, MA) transwell inserts (Costar, Cambridge, MA) according to a previously described procedure (Mohanam et al., 1993) . Brie¯y, transwell inserts with 8 mm pore size were coated with a ®nal concentration of 0.78 mg/ml of Matrigel in cold serum-free DMEM. Cells were trypsinized and 200 ml of cell suspension (1610 6 cells/ml) from each treatment was added in triplicate wells. After 48 h incubation, the cells that passed through the ®lter into the lower wells were quantitated by MTT assay, and expressed as a percentage of the sum of the cells in the upper and lower wells (Mohanam et al., 1993) .
Glioma spheroids
Multicellular glioma spheroids were cultured in 100 mm 2 tissue-culture plates (Corning, Inc., Corning, NY) precoated with 0.75% agar (Difco Laboratories, Inc., Detroit, MI) prepared in DMEM according to a previously described method (Pedersen et al., 1993) . Brie¯y, 3610 6 cells were suspended in 10 ml medium, seeded onto 0.75% agar plates, and cultured until spheroids were formed. Spheroids of 100 ± 200 mm diameter were selected for use in further experiments. After 7 days in culture, spheroids were incubated with¯uorescent dye DiO and confronted with brain-cell aggregates that have been stained with DiI. The carbocyanin dyes DiO [DioC 18 (3)] and DiI [DiIC 18 (3)] were obtained from Molecular Probes, Inc, (Eugene, OR), and the staining was performed as described elsewhere (Pedersen et al., 1993) .
Fetal rat-brain aggregates
Fetal rat-brain aggregates were obtained from 18 day-old fetuses of Sprague-Dawley rats. The brains were aseptically removed and placed into a sterile tissue-culture plate containing phosphate-buered saline (PBS, pH 7.2). The brain tissue was minced, washed in PBS, and dissociated by serial trypsinization (0.025% trypsin, Sigma Chemical Co., St Louis). Single-cell suspension was obtained and plated into agar-coated 16 mm multiwell dishes at a concentration of 6610 6 cell/ml (Pedersen et al., 1993) . After 48 h, aggregates were transferred onto new plates and cultured for 16 days. Aggregates with 100 ± 200 mm diameter were used in further experiments.
Confocal laser scanning microscopy
Invasion of the tumor spheroids into fetal rat-brain aggregates was analysed by confocal Laser Scanning Microscopy (Zeiss LSM210, Thornwood, NY; Nygaard et al., 1995) . Brie¯y, DiO-stained tumor spheroids and DiIstained fetal rat-brain aggregates were washed in the medium and transferred in quadruplicate to individual wells of a 96-well plate, base-coated with agar. With the help of a sterile syringe and a stereomicroscope, tumor spheroids and fetal rat-brain aggregates were placed in close contact to each other. At dierent time intervals, serial 1 mM-thick optical sections were obtained from the surface to the center of the co-cultures by a confocal laser scanning microscope. Detection of DiI and DiO fluorescence was done by using an argon laser at 488 nm with a band pass ®lter 520 ± 560 nm and a helium/neon laser at 543 nm with a long pass ®lter at 590 nm, respectively.
Analysis of MMP-2
Analysis of MMP-2 was performed with sodium dodecyl sulfate-polyacrylamide gels impregnated with 0.1% gelatin (w/v) and 10% polyacrylamide (w/v) as described elsewhere (Nakajima et al., 1990 ). Cells were grown in 100 mm 2 tissue-culture plates in DMEM containing 10% FBS until they reached 80% con¯uency. Cells were washed and replaced with serum-free medium, and the conditioned medium was collected after 48 h. Four parts of medium containing equal amounts of protein (50 mg) were mixed with one part of Laemmli sample buer (minus reductant) (Laemmli 1970) prior to electrophoresis. Gels were run at a constant current and then washed twice for 30 min in 50 mM Tris-HCl, pH 7.5, plus 2.5% Triton X-100, and then incubated overnight at 378C in 50 mM Tris-HCl, pH 7.6, 10 mM CaCl 2 , 150 mM NaCl, 0.05% NaN 3 . Gels were stained with Coomassie Brilliant Blue R-250 and then destained.
